Medtronic kept at market outperform by JMP

Medtronic, Inc. was maintained at a market outperform rating by JMP Securities analyst Robert C. Faulkner after the company announced its intention to issue up to $4.4 billion of convertible debt to be used for share repurchases and retirement of existing debt. Three is a potential for an acquisition, with Zimmer Holdings an attractive candidate. JMP calculates potential earnings per share accretion of $0.07 in 2007 and $0.08 in 2008. Shares of the Minneapolis medical device company were up $0.54, or 1.07%, at $51.04 on volume of 7,491,500 shares versus the three-month running average of 4,510,470 shares. (NYSE: MDT)

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.